[The Business Times] NYB's AI-First Drug Discovery Part of Singapore's Healthcare Innovation Drive
Professor Daniel Ting, director of the SingHealth AI Office, told the paper that estimates AI could reduce costs across the medical product life cycle by as much as half, by helping researchers surface promising molecules earlier, match patients to trials, and avoid expensive dead ends.
To support these points, NYB was highlighted as an example of AI-powered drug discovery.
